Hyperactivity News and Research

RSS

New advice about the use of Strattera (atomoxetine)

New advice to doctors and patients about the use of Strattera, (atomoxetine), was issued today by the Medicines and Healthcare products Regulatory Agency, (MHRA).

3 Feb 2005

Astonishing discovery that could change our understanding of attention deficit disorders

British researchers from Brunel University have made an astonishing discovery that could change our understanding of attention deficit, impulsivity and hyperactivity disorder (ADHD).

18 Jan 2005

Seven percent of college students have used prescription stimulants for non-medical purposes

Seven percent of college students have used prescription stimulants for non-medical purposes over their lifetimes and 4 percent have used in the past year, according to a study of students at 119 four-year colleges and universities nationwide published in the January issue of the journal Addiction.

10 Jan 2005

Restless legs syndrome is underdiagnosed in kids

A new Mayo Clinic study has for the first time established rates of restless legs syndrome in children, finding that almost 6 percent of children seen in Mayo's sleep clinic have the disease.

28 Dec 2004

Early ritalin may cause long-term effects on the brain

A new study conducted in rats by the National Institutes of Health (NIH) and McLean Hospital/Harvard Medical School suggests that the misdiagnosis of attention-deficit hyperactivity disorder (ADHD) combined with prescription drug use in children may lead to a higher risk of developing depressive symptoms in adulthood.

13 Dec 2004

Newly discovered genetic defect might represent an important risk factor for major depression

A newly discovered genetic defect might represent an important risk factor for major depression, a condition which effects 20 million people in the U.S., according to Duke University Medical Center researchers.

13 Dec 2004

Life expectancy at 65 is now 81.6 years for men and 84.5 for women

The nation’s medicine cabinets are more crowded than ever, with almost half of all people taking at least one prescription medicine and one in six taking three or more medications, according to the U.S. Department of Health and Human Services’ annual check-up on Americans’ health.

4 Dec 2004

Children with ADHD have abnormal fiber pathways in the frontal cortex

Children with attention deficit hyperactivity disorder (ADHD) display anatomical brain abnormalities beyond chemical imbalance, according to research presented at the annual meeting of the Radiological Society of North America (RSNA).

29 Nov 2004

Researcher highlights hidden problem of smoking after pregnancy

Most women know to drop cigarettes and alcohol while they are pregnant. In fact, about half of women smokers now quit smoking when they become pregnant.

9 Nov 2004

First home-testing device for phenylketonuria (PKU) patients

Home-testing kits have made it easier for diabetics and hypertension patients to track their conditions, but such self-monitoring hasn’t been possible for people with phenylketonuria (PKU).

1 Nov 2004

Flame retardants may cause brain damage

Reduced adaptability, hyperactivity, and disturbances in memory and learning functions. These are deficiencies mice and rats evince when exposed to bromide flame retardants, such as those found in computers, textiles, and other materials in our surroundings, during the period when the brain develops most rapidly.

1 Nov 2004

Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder

Hispanic children are less likely to be diagnosed with attention deficit and hyperactivity disorder during primary care visits than white or black children are, according to a new study that looks at children's physician visits nationwide.

29 Oct 2004

Innovative guide for Moms, Kids with ADD

Unlike other ADD parenting guides, "When Moms and Kids Have ADD" is ADD- friendly. Bold topic headings, bulleted lists, clear print, eye-catching graphics and summaries make the guide easy for an ADD parent to read.

26 Oct 2004

Carers of dementing family members can exacerbate the dementing patient’s problematic behaviour

During her doctoral research, De Vugt identified three strategies that care-providing family members adopt to approach the dementing patient. The 'supportive strategy', in which the carer adjusts to the patient's level of functioning, is the most effective. Equally a 'caring strategy', in which the carer considers the patient to be more like a child, gives rise to little restlessness in the patient.

11 Oct 2004

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

An intriguing link between a mother’s stress levels during pregnancy and the effect on the brain of her unborn baby is revealed in a new study of children born in Bristol, England.

20 Sep 2004

Total abstinence is the only way to protect the unborn baby against Foetal Alcohol Syndrome

Is there a safe level of alcohol consumption during pregnancy? Biochemist Kathy Kitson says the answer is no – total abstinence is the only way to protect the unborn baby against Foetal Alcohol Syndrome.

15 Sep 2004

Boys generally at greater risk of developing attention-deficit/hyperactivity disorder

Boys, in general, and children born to parents who have low education levels, in particular, are at an increased risk for developing attention-deficit/hyperactivity disorder (ADHD) compared to girls and children born to parents with high levels of education, according to a study of 5,701 children in Olmsted County, Minn.

14 Sep 2004

Chemical pathways of serotonin in the nervous system pave way for future pharmaceutical treatments for depression

From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.

10 Sep 2004

Attention deficit hyperactivity disorder costs the U.S. $77 billion each year

A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.

9 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004